Type-I interferon receptor expression: Its circadian rhythm and downregulation after interferon-α administration in peripheral blood cells from renal cancer patients

被引:10
|
作者
Shiba, Masahiro [1 ]
Nonomura, Norio [1 ]
Nakai, Yasutomo [1 ]
Nakayama, Masashi [1 ]
Takayama, Hitoshi [1 ]
Inoue, Hitoshi [1 ]
Tsujimura, Akira [1 ]
Nishimura, Kazuo [1 ]
Okuyama, Akihiko [1 ]
机构
[1] Osaka Univ, Grad Sch Med, Dept Urol, Suita, Osaka 5650871, Japan
关键词
circadian rhythm; downregulation; interferon; receptor; renal cell carcinoma; RANDOMIZED PHASE-II; BETA RECEPTOR; SUBUNIT; CLONING; CLOCK; TRIAL;
D O I
10.1111/j.1442-2042.2009.02265.x
中图分类号
R5 [内科学]; R69 [泌尿科学(泌尿生殖系疾病)];
学科分类号
1002 ; 100201 ;
摘要
Objectives: To investigate the regulation of interferon-alpha (IFN-alpha) receptor expression in metastatic renal cell carcinoma (RCC) after IFN-alpha administration. Methods: Blood sampling was carried out in eight patients with metastatic RCC and six healthy volunteers. Flow-cytometric analysis using a monoclonal antibody against the active subunit of the type-I IFN-alpha receptor (IFNAR2) was carried out to examine the circadian rhythm of IFNAR2 expression in peripheral blood mononuclear cells (PBMC) as well as its downregulation after IFN-alpha administration. Results: According to its circadian rhythm IFNAR2 in PBMC had a peak expression at night. Once IFN-alpha is administered, IFNAR2 levels in PBMC showed downregulation within 48 h and recovered within another 48 h. Conclusions: Our findings might support the establishment of an optimal schedule for IFN-alpha administration.
引用
收藏
页码:356 / 359
页数:4
相关论文
共 50 条
  • [1] Interferon-α receptor 1 mRNA expression in peripheral blood mononuclear cells is associated with response to interferon-α therapy of patients with chronic hepatitis C
    Massirer, KB
    Hirata, MH
    Silva, AEB
    Ferraz, MLG
    Nguyen, NY
    Hirata, RDC
    BRAZILIAN JOURNAL OF MEDICAL AND BIOLOGICAL RESEARCH, 2004, 37 (05) : 643 - 647
  • [2] Influence of type-I Interferon receptor expression level on the response to type-I Interferons in human pancreatic cancer cells
    Booy, Stephanie
    van Eijck, Casper H. J.
    Dogan, Fadime
    van Koetsveld, Peter M.
    Hofland, Leo J.
    JOURNAL OF CELLULAR AND MOLECULAR MEDICINE, 2014, 18 (03) : 492 - 502
  • [3] Expression of Type I Interferon Receptor in Liver and Peripheral Blood Mononuclear Cells in Chronic Hepatitis C Patients
    Yuhki Yamaguchi
    Keisuke Hino
    Daisuke Fujiwara
    Fenyu Ren
    Yoshiharu Katoh
    Yasuhiro Satoh
    Kiwamu Okita
    Digestive Diseases and Sciences, 2002, 47 : 1611 - 1617
  • [4] Expression of type I interferon receptor in liver and peripheral blood mononuclear cells in chronic hepatitis C patients
    Yamaguchi, Y
    Hino, K
    Fujiwara, D
    Ren, F
    Katoh, Y
    Satoh, Y
    Okita, K
    DIGESTIVE DISEASES AND SCIENCES, 2002, 47 (07) : 1611 - 1617
  • [5] Expression of interferon-α subtypes in peripheral mononuclear cells from patients with chronic hepatitis C:: a role for interferon-α5
    Larrea, E
    Alberdi, A
    Castelruiz, Y
    Boya, P
    Civeira, MP
    Prieto, J
    JOURNAL OF VIRAL HEPATITIS, 2001, 8 (02) : 103 - 110
  • [6] Interferon-α receptor dependent and independent inhibition of type I interferon production in plasmacytoid dendritic cells from mice and melanoma patients
    Huang, Xue-Fei
    Gelbard, Alexander
    Li, Haiyan S.
    Rodriguez-Cruz, Tania G.
    Lou, Yanyan
    Liu, Chengwen
    Hailemichael, Yared
    Nanda, Vashisht G. Yennu
    Davies, Michael A.
    Liu, Yong-Jun
    Watowich, Stephanie S.
    Overwijk, Willem W.
    CANCER RESEARCH, 2012, 72
  • [7] Type-I interferon pathway and DNA damage accumulation in peripheral blood of patients with psoriatic arthritis
    Fragoulis, George E.
    Ntouros, Panagiotis A.
    Nezos, Adrianos
    Vlachogiannis, Nikolaos I.
    Mcinnes, Iain B.
    Tektonidou, Maria G.
    Skarlis, Charalampos
    Souliotis, Vassilis L.
    Mavragani, Clio P.
    Sfikakis, Petros P.
    FRONTIERS IN IMMUNOLOGY, 2023, 14
  • [8] Type 2 dendritic cells (interferon-α producing cells) are significantly reduced in peripheral blood of chronic myelogenous leukemia patients in remission with interferon-α or Gleevec.
    Gao, H
    Talpaz, M
    Lee, BN
    Mbawuike, IN
    Cortes, JE
    Talpaz, M
    Lee, BN
    Mbawuike, IN
    Cortes, JE
    Kantarjian, HM
    Reuben, JM
    BLOOD, 2003, 102 (11) : 655A - 655A
  • [9] The Interleukine-10 And Interferon-γmrna Expression Of Peripheral Blood Mononuclear Cells In Patients With Sarcoidosis
    Ando, M.
    Yamasue, M.
    Yoshikawa, H.
    Toba, S.
    Umeki, K.
    Nureki, S. -I.
    Kadota, J. -I.
    AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2016, 193
  • [10] TYPE I INTERFERON INDUCED GENE EXPRESSION IN THE PERIPHERAL BLOOD OF PATIENTS WITH SYSTEMIC SCLEROSIS
    Vlachogiannis, N.
    Bournia, V.
    Nezos, A.
    Christopoulos, P. F.
    Patsouras, M.
    Vlachoyiannopoulos, P. G.
    Mavragani, C. P.
    Sfikakis, P. P.
    CLINICAL AND EXPERIMENTAL RHEUMATOLOGY, 2018, 36 (01) : S33 - S34